Toxicologic investigations on moquizone (1-morpholinoacetyl-3-phenyl-2,3-dihydro-4(1H)-quinazolone).
D000818:Animals; D001772:Blood Cell Count; D001773:Blood Cells / Q000187:drug effects; D001774:Blood Chemical Analysis; D001835:Body Weight / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D002756:Cholagogues and Choleretics / Q000032:analysis / Q000097:blood / Q000633:toxicity*; D004285:Dogs; D005260:Female; D006128:Growth / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D009025:Morpholines / Q000032:analysis / Q000097:blood / Q000633:toxicity*; D009043:Motor Activity / Q000187:drug effects; D011799:Quinazolines / Q000032:analysis / Q000097:blood / Q000633:toxicity*; D011817:Rabbits; D051381:Rats; D013045:Species Specificity
D002756:Cholagogues and Choleretics; D009025:Morpholines; D011799:Quinazolines